On-Demand Webinar
Overview
The Second Edition of the FACT Standards for Immune Effector Cells was published on December 15, 2023, and became effective on March 15, 2024. Nic Prokopishyn, PhD, Chair of the FACT Standards Development Committee, walks through and explains changes made from the first edition.
Speaker(s)
Nicole Prokopishyn, PHD
Cellular Therapy Lab Director
Alberta Blood and Marrow Transplant Program
Dr. Nicole Prokopishyn is currently serving as the Cellular Therapy Lab Director at the Alberta Blood and Marrow Transplant Program: Foothills Medical Centre, Alberta Children’s Hospital, Tom Baker Cancer Centre, and Calgary Laboratory Services. In this role, she oversees the provision of services for adult and pediatric transplants and cellular therapy. Nicole obtained her PhD in Biochemistry from the University of Saskatchewan. After completing her studies, she spent 10 years working abroad, with 5 years in Houston and 5 years in Philadelphia. During her time in these locations, she focused on the development of gene editing technologies in blood stem cells for the treatment of sickle cell disease and hemophilia. Nicole returned to Canada and accepted the director role at the Alberta Blood and Marrow Transplant Program, combining her expertise in quality assurance with a passion for treating patients through transplant and cellular therapy. Throughout her career, she has written numerous articles and presented her research findings internationally in the field of Cellular Therapy. Currently, she serves as the Chair of FACT's Standards Development Committee. In this role, she contributes to the development and enhancement of quality standards in this specialized field. Dr. Prokopishyn's extensive experience, dedication to improving patient outcomes, and commitment to advancing knowledge in the field make her one of the leading authorities in Cellular Therapy. Dr. Prokopishyn has been a FACT Inspector since 2013.
Complete
Next
Failed
Available
Locked